BioSpace News Archive

Lysogene, a pioneering Phase 3 biopharmaceutical company specializing in gene therapy targeting central nervous system diseases, reports its cash position as of 31 December 2019.

New sites to recruit voluntary military personnel in ongoing Phase 2 study in Sudden Sensorineural Hearing Loss

The board of Orexo AB has resolved, pursuant to the authorisation granted by the annual general meeting held on 11 April 2019, to initiate a repurchase program of ordinary shares.

PharmaMar and Jazz Pharmaceuticals plc announce that the U.S. Food and Drug Administration accepted for filing with Priority Review the New Drug Application seeking accelerated approval for lurbinectedin for the treatment of patients with Small Cell Lung Cancer who have progressed after prior platinum-containing therapy.

Fresenius Kabi announces that the Journal of Parenteral and Enteral Nutrition has recently published “Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice”.[1] The publication represents the largest set of expert consensus statements to provide guidance on the use of fish oil-containing lipid emulsions in clinical practice.

Recently, Ping An Healthcare and Technology Company Limited, the world’s leading healthcare ecosystem platform, released its 2019 Environmental, Social and Governance Report.

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced the Company’s Board of Directors has elected Robert Friel as its newest member.

RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that Chief Medical Officer Raj Malik, M.D., will participate in the “Breast Cancer – The Moving Landscape” panel discussion at the BTIG Targeted Therapeutics Conference. The conference will take place on Monday, February 24, 2020 at the St. Regis Hotel in New York, NY. About G1 Therapeutics G1 Therapeutics, Inc. is a clinical-stage bio

MINNEAPOLIS , Feb. 17, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel , Chief Financial Officer, will present at the SVB Leerink 9 th Annual Global Healthcare Conference on Wednesday, February 26, 2020 at 11:30 a.m. EST . The conference will be held at the Lotte New York Palace in New York, NY . A live webcast of the presentatio

Feb. 17, 2020 12:00 UTC NESS ZIONA, Israel--( BUSINESS WIRE )-- BiomX , a microbiome company developing both natural and engineered phage therapies, today announced that the company will present pre-clinical data from its colorectal cancer program at the plenary session of the American Association for Cancer Research (AACR) Microbiome, Viruses, and Cancer Conference taking place from February 21-24, 2020, in Orlando, Florida. BiomX’s colorectal cancer program utilizes phage to targ